Galderma Group AG

Equities

GALD

CH1335392721

Personal Products

Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
66.79 CHF -0.79% Intraday chart for Galderma Group AG +3.36% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... Our Logo
Switzerland's Galderma posts 12.4% jump in first-quarter sales RE
Transcript : Galderma Group AG, Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024
Galderma Group Logs Higher Q1 Net Sales, Affirms FY24 Guidance MT
Bankers lose hope of London IPO revival for another year RE
Swiss Equities Flash Green; Middle East Tensions Rise MT
EQT Client Assets Rise While Investments, Fund Exits Slip DJ
European IPO Activity Picks Up -- At a Glance DJ
Spanish cosmetics group Puig seeks at least $2.7 bln in local IPO RE
Moody's Lifts Galderma's Ratings Following Recent IPO in Switzerland MT
Global IPO revival lags first quarter share sales as markets rally RE
Galderma's IPO Proceeds Rise to CHF2.3 Billion with Exercise of Overallotment Option MT
Galderma underwriters buy $330 mln worth shares from existing shareholder RE
Swiss Equities Ends Central Bank Week in the Red; Galderma Shines on Debut MT
Galderma Starts Trading on SIX Swiss Exchange MT
Galderma Prices Swiss IPO at Top End of Range MT
Galderma sets final price for IPO at top of range RE
Galderma Group AG has completed an IPO in the amount of CHF 1.988063 billion. CI
GALDERMA: COMPANY WILL BE INCLUDED IN THE SWISS PERFORMANCE IN… RE
GALDERMA: THE LISTING AND FIRST DAY OF TRADING ARE EXPECTED… RE
GALDERMA: PRICE RANGE RESULTS IN OFFER SIZE OF ROUGHLY 2.3 BLN… RE
GALDERMA: THE PRICE RANGE FOR THE OFFERED SHARES HAS BEEN SET… RE
GALDERMA: THE OFFERING CONSISTS OF UP TO 40,453,467 NEWLY ISSU… RE
Chart Galderma Group AG
More charts
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. GALD Stock
  4. News Galderma Group AG
  5. Galderma's IPO Proceeds Rise to CHF2.3 Billion with Exercise of Overallotment Option